Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk

Breast Cancer Research and Treatment

Volumn 118, Issue 2, 2009, Pages 407-413

  Yang, Rongxi ^a,b   Chen, Bowang ^a   Hemminki, Kari ^a,c   Wappenschmidt, Barbara ^d,e   Engel, Christoph ^f   Sutter, Christian ^b   Ditsch, Nina ^g   Weber, Bernhard H F ^h   Niederacher, Dieter ⁱ   Arnold, Norbert ^j   Meindl, Alfons ^k   Bartram, Claus R ^b   Schmutzler, Rita K ^d,e   Burwinkel, Barbara ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g UNIVERSITY OF MUNICH   (Germany)

^h UNIVERSITY OF REGENSBURG   (Germany)

ⁱ HEINRICH HEINE UNIVERSITY   (Germany)

^j UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^k TECHNICAL UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

BRCA1; BRCA2; Breast cancer risk; Case control study; Codon usage

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BRCA2 GENE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CODON USAGE; FAMILIAL CANCER; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CODON; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 70350218734     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0348-7     Document Type: Article

References (50)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 10.3322/canjclin.55.2.74 15761078
2. JL Hopper 2001 Genetic epidemiology of female breast cancer Semin Cancer Biol 11 367 374 10.1006/scbi.2001.0392 10.1006/scbi.2001.0392 1:CAS:528:DC%2BD3MXmvVGgtrk%3D 11562179 (Pubitemid 33016032)
3. SA Narod 2002 Modifiers of risk of hereditary breast and ovarian cancer Nat Rev Cancer 2 113 123 10.1038/nrc726 10.1038/nrc726 12635174
4. K Czene P Lichtenstein K Hemminki 2002 Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database Int J Cancer 99 260 266 10.1002/ijc.10332 10.1002/ijc.10332 1:CAS:528: DC%2BD38XivFyrs7o%3D 11979442 (Pubitemid 34309484)
5. P Lichtenstein NV Holm PK Verkasalo A Iliadou J Kaprio M Koskenvuo E Pukkala A Skytthe K Hemminki 2000 Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 78 85 10.1056/NEJM200007133430201 10.1056/ NEJM200007133430201 1:STN:280:DC%2BD3czjtFCiug%3D%3D 10891514 (Pubitemid 30451850)
6. K Hemminki R Rawal B Chen JL Bermejo 2004 Genetic epidemiology of cancer: from families to heritable genes Int J Cancer 111 944 950 10.1002/ijc.20355 10.1002/ijc.20355 1:CAS:528:DC%2BD2cXntVant7c%3D 15300808 (Pubitemid 39096245)
7. PD Pharoah NE Day S Duffy DF Easton BA Ponder 1997 Family history and the risk of breast cancer: a systematic review and meta-analysis Int J Cancer 7 800 809 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B (Pubitemid 27237202)
8. A Meindl 2002 Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population Int J Cancer 97 472 480 10.1002/ijc.1626 10.1002/ijc.1626 1:CAS:528:DC%2BD38XkvFegtg%3D%3D 11802209 (Pubitemid 34027806)
9. Y Miki J Swensen D Shattuck-Eidens PA Futreal K Harshman S Tavtigian Q Liu C Cochran LM Bennett W Ding, et al. 1994 A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66 71 10.1126/science.7545954 10.1126/science.7545954 1:CAS:528:DyaK2MXhtF2ns70%3D 7545954 (Pubitemid 24345325)
10. R Wooster G Bignell J Lancaster S Swift S Seal J Mangion N Collins S Gregory C Gumbs G Micklem 1995 Identification of the breast cancer susceptibility gene BRCA2 Nature 378 789 792 10.1038/378789a0 10.1038/378789a0 1:CAS:528:DyaK28XltFWi 8524414 (Pubitemid 26004412)
11. DF Easton AM Deffenbaugh D Pruss C Frye RJ Wenstrup K Allen-Brady SV Tavtigian AN Monteiro ES Iversen FJ Couch, et al. 2007 A systematic genetic assessment of 1, 433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes Am J Hum Genet 81 873 883 10.1086/521032 10.1086/521032 1:CAS:528:DC%2BD2sXht1KmsL%2FP 17924331 (Pubitemid 47580242)
12. R Wooster BL Weber 2003 Breast and ovarian cancer N Engl J Med 348 2339 2347 10.1056/NEJMra012284 10.1056/NEJMra012284 1:CAS:528:DC%2BD3sXkt1Kktrc%3D 12788999 (Pubitemid 36638109)
13. MS Brose TR Rebbeck KA Calzone JE Stopfer KL Nathanson BL Weber 2002 Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program J Natl Cancer Inst 94 1365 1372 1:CAS:528: DC%2BD38Xnt1Gnurg%3D 12237282
14. D Thompson DF Easton 2002 Cancer Incidence in BRCA1 mutation carriers J Natl Cancer Inst 94 1358 1365 1:CAS:528:DC%2BD38Xnt1Gnurs%3D 12237281 (Pubitemid 35154140)
15. DJ Hughes 2008 Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers Fam Cancer 7 233 244 10.1007/s10689-008-9181-0 10.1007/s10689-008-9181-0 1:CAS:528: DC%2BD1cXptVKksbs%3D 18283561
16. F Esashi N Christ J Gannon Y Liu T Hunt M Jasin SC West 2005 CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair Nature 434 598 604 10.1038/nature03404 10.1038/nature03404 1:CAS:528:DC%2BD2MXislCmsr0%3D 15800615 (Pubitemid 40488546)
17. TR Rebbeck Y Wang PW Kantoff K Krithivas SL Neuhausen AK Godwin MB Daly SA Narod JS Brunet D Vesprini, et al. 2001 Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history Cancer Res 61 5420 5424 1:CAS:528:DC%2BD3MXlsVChs7g%3D 11454686
18. AC Antoniou AB Spurdle OM Sinilnikova S Healey KA Pooley RK Schmutzler B Versmold C Engel A Meindl N Arnold, et al. 2008 Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers Am J Hum Genet 82 937 948 10.1016/j.ajhg.2008.02.008 10.1016/j.ajhg.2008.02.008 1:CAS:528:DC%2BD1cXltVKrsbc%3D 18355772
19. R Duan C Pak P Jin 2007 Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA Hum Mol Genet 16 1124 1131 10.1093/hmg/ddm062 10.1093/hmg/ddm062 1:CAS:528:DC%2BD2sXntVKqsb8%3D 17400653 (Pubitemid 47062732)
20. X Wang DJ Tomso X Liu DA Bell 2005 Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes Toxicol Appl Pharmacol 207 84 90 10.1016/j.taap.2004.09.024 10.1016/j.taap.2004.09.024 16002116 (Pubitemid 41265500)
21. D GuhaThakurta T Xie M Anand SW Edwards G Li SS Wang EE Schadt 2006 Cis-regulatory variations: a study of SNPs around genes showing cis-linkage in segregating mouse populations BMC Genomics 7 235 10.1186/1471-2164-7-235 10.1186/1471-2164-7-235 16978413 (Pubitemid 44604583)
22. R Yang B Frank K Hemminki CR Bartram B Wappenschmidt C Sutter M Kiechle P Bugert RK Schmutzler N Arnold, et al. 2008 SNPs in ultraconserved elements and familial breast cancer risk Carcinogenesis 29 351 355 10.1093/carcin/bgm290 10.1093/carcin/bgm290 1:CAS:528:DC%2BD1cXislKhsbk%3D 18174240 (Pubitemid 351359674)
23. JB Fan MS Chee KL Gunderson 2006 Highly parallel genomic assays Nat Rev Genet 7 632 644 10.1038/nrg1901 10.1038/nrg1901 1:CAS:528:DC%2BD28XmvFCnu7c%3D 16847463 (Pubitemid 44100520)
24. C Kiyohara K Yoshimasu 2007 Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis Int J Med Sci 4 59 71 1:CAS:528:DC%2BD2sXms1KrsrY%3D 17299578
25. C Kimchi-Sarfaty JM Oh IW Kim ZE Sauna AM Calcagno SV Ambudkar MM Gottesman 2007 A "silent" polymorphism in the MDR1 gene changes substrate specificity Science 315 525 528 10.1126/science.1135308 10.1126/science.1135308 1:CAS:528:DC%2BD2sXotFCitA%3D%3D 17185560 (Pubitemid 46175758)
26. ZE Sauna C Kimchi-Sarfaty SV Ambudkar MM Gottesman 2007 Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer Cancer Res 67 9609 9612 10.1158/0008-5472.CAN-07-2377 10.1158/0008-5472.CAN-07-2377 1:CAS:528:DC%2BD2sXhtFOnsLnO 17942888 (Pubitemid 47621204)
27. K Jamroziak E Balcerczak P Smolewski RW Robey B Cebula M Panczyk M Kowalczyk A Szmigielska-Kaplon M Mirowski SE Bates, et al. 2006 MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia Pharmacol Rep 58 720 728 1:CAS:528: DC%2BD2sXpsFGgtw%3D%3D 17085864
28. YJ Liou YC Wang JY Chen ML Chen TT Chen YM Bai CC Lin DL Liao IC Lai 2008 The coding-synonymous polymorphism rs1045280 (Ser280Ser) in beta-arrestin 2 (ARRB2) gene is associated with tardive dyskinesia in Chinese patients with schizophrenia Eur J Neurol 15 1406 1408 10.1111/j.1468-1331.2008.02316.x 10.1111/j.1468-1331.2008.02316.x 19049562
29. KE Knobe E Sjorin RC Ljung 2008 Why does the mutation G17736A/Val107Val (silent) in the F9 gene cause mild haemophilia B in five Swedish families? Haemophilia 14 723 728 10.1111/j.1365-2516.2008.01753.x 10.1111/j.1365-2516. 2008.01753.x 1:CAS:528:DC%2BD1cXps1Glsbo%3D 18459950 (Pubitemid 352016027)
30. AA Komar 2007 Genetics SNPs, silent but not invisible Science 315 466 467 10.1126/science.1138239 10.1126/science.1138239 1:CAS:528:DC%2BD2sXhtFOqsLs%3D 17185559 (Pubitemid 46178389)
31. S Brunak J Engelbrecht 1996 Protein structure and the sequential structure of mRNA: alpha-helix and beta-sheet signals at the nucleotide level Proteins 25 237 252 10.1002/(SICI)1097-0134(199606)25:2<237::AID-PROT9>3. 3.CO;2-Y 10.1002/(SICI)1097-0134(199606)25:2<237::AID-PROT9>3.3.CO;2-Y 1:CAS:528:DyaK28XktlShu7o%3D 8811739
32. SK Gupta S Majumdar TK Bhattacharya TC Ghosh 2000 Studies on the relationships between the synonymous codon usage and protein secondary structural units Biochem Biophys Res Commun 269 692 696 10.1006/bbrc.2000.2351 10.1006/bbrc.2000.2351 1:CAS:528:DC%2BD3cXhslequrk%3D 10720478 (Pubitemid 30440363)
33. P Cortazzo C Cervenansky M Marin C Reiss R Ehrlich A Deana 2002 Silent mutations affect in vivo protein folding in Escherichia coli Biochem Biophys Res Commun 293 537 541 10.1016/S0006-291X(02)00226-7 10.1016/S0006-291X(02)00226-7 1:CAS:528:DC%2BD38XksVGhs7w%3D 12054634 (Pubitemid 34694241)
34. RJ Epstein K Lin TW Tan 2000 A functional significance for codon third bases Gene 245 291 298 10.1016/S0378-1119(00)00042-1 10.1016/S0378-1119(00) 00042-1 1:CAS:528:DC%2BD3cXhs12isbo%3D 10717480 (Pubitemid 30136434)
35. JR Powell EN Moriyama 1997 Evolution of codon usage bias in Drosophila Proc Natl Acad Sci USA 94 7784 7790 10.1073/pnas.94.15.7784 10.1073/pnas.94.15. 7784 1:CAS:528:DyaK2sXksl2nsbo%3D 9223264 (Pubitemid 27343726)
36. F Capon MH Allen M Ameen AD Burden D Tillman JN Barker RC Trembath 2004 A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups Hum Mol Genet 13 2361 2368 10.1093/hmg/ddh273 10.1093/hmg/ddh273 1:CAS:528: DC%2BD2cXnvVOku70%3D 15333584 (Pubitemid 39377840)
37. KB Nielsen S Sorensen L Cartegni TJ Corydon TK Doktor LD Schroeder LS Reinert O Elpeleg AR Krainer N Gregersen, et al. 2007 Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer Am J Hum Genet 80 416 432 10.1086/511992 10.1086/511992 1:CAS:528:DC%2BD2sXit1Wlu7g%3D 17273963 (Pubitemid 46310974)
38. B Burwinkel M Wirtenberger R Klaes RK Schmutzler E Grzybowska A Forsti B Frank JL Bermejo P Bugert B Wappenschmidt, et al. 2005 Association of NCOA3 polymorphisms with breast cancer risk Clin Cancer Res 11 2169 2174 10.1158/1078-0432.CCR-04-1621 10.1158/1078-0432.CCR-04-1621 1:CAS:528: DC%2BD2MXisFajur4%3D 15788663 (Pubitemid 40490174)
39. WD Dupont WD Plummer Jr 1998 Power and sample size calculations for studies involving linear regression Control Clin Trials 19 589 601 10.1016/S0197-2456(98)00037-3 10.1016/S0197-2456(98)00037-3 1:STN:280: DyaK1M%2FptFSnsA%3D%3D 9875838 (Pubitemid 29057724)
40. M Loizidou Y Marcou V Anastasiadou R Newbold A Hadjisavvas K Kyriacou 2007 Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus Clin Genet 71 165 170 10.1111/j.1399-0004. 2007.00747.x 10.1111/j.1399-0004.2007.00747.x 1:STN:280:DC%2BD2s%2FkslClsA%3D%3D 17250666 (Pubitemid 46189221)
41. JD Fackenthal OI Olopade 2007 Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations Nat Rev Cancer 7 937 948 10.1038/nrc2054 10.1038/nrc2054 1:CAS:528:DC%2BD2sXhtlCrsLbK 18034184 (Pubitemid 350165853)
42. FB Hogervorst PM Nederlof JJ Gille CJ McElgunn M Grippeling R Pruntel R Regnerus T van Welsem R van Spaendonk FH Menko, et al. 2003 Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method Cancer Res 63 1449 1453 1:CAS:528:DC%2BD3sXisFais7g%3D 12670888
43. Anglian Breast Cancer Study Group 2000 Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases Br J Cancer 83 1301 1308 10.1054/bjoc.2000.1407 10.1054/bjoc.2000.1407
44. BB Roa AA Boyd K Volcik CS Richards 1996 Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 Nat Genet 14 185 187 10.1038/ng1096-185 10.1038/ng1096-185 1:CAS:528:DyaK28XmtVKntLs%3D 8841191 (Pubitemid 26338801)
45. D Palli M Falchetti G Masala R Lupi F Sera C Saieva C D'Amico M Ceroti P Rizzolo MA Caligo, et al. 2007 Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany Central Italy BMC Cancer 7 170 10.1186/1471-2407-7-170 10.1186/1471-2407-7-170 17767707
46. N Johnson O Fletcher C Palles M Rudd E Webb G Sellick I s Silva V McCormack L Gibson A Fraser, et al. 2007 Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility Hum Mol Genet 16 1051 1057 10.1093/hmg/ddm050 10.1093/hmg/ddm050 1:CAS:528: DC%2BD2sXntVKqsLo%3D 17341484 (Pubitemid 47062726)
47. ML Freedman KL Penney DO Stram L Le Marchand JN Hirschhorn LN Kolonel D Altshuler BE Henderson CA Haiman 2004 Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort Hum Mol Genet 13 2431 2441 10.1093/hmg/ddh270 10.1093/hmg/ddh270 1:CAS:528: DC%2BD2cXnvVOkurk%3D 15317758 (Pubitemid 39377847)
48. RS Houlston J Peto 2003 The future of association studies of common cancers Hum Genet 112 434 435 12574941
49. AC Antoniou DF Easton 2003 Polygenic inheritance of breast cancer: implications for design of association studies Genet Epidemiol 25 190 202 10.1002/gepi.10261 10.1002/gepi.10261 14557987 (Pubitemid 37296594)
50. P Schattner M Diekhans 2006 Regions of extreme synonymous codon selection in mammalian genes Nucleic Acids Res 34 1700 1710 10.1093/nar/gkl095 10.1093/nar/gkl095 1:CAS:528:DC%2BD28XjslKqtLk%3D 16556911